AI Article Synopsis

  • The study compared two techniques for imaging coronary arteries using 1.5-T MRA: volume-targeted acquisition and whole-heart acquisition.
  • Both techniques were analyzed in 36 subjects, showing similar navigator efficiency and signal-to-noise ratios but volume-targeted acquisition provided higher contrast-to-noise ratios.
  • While the whole-heart method took longer and was better for visualizing certain arteries, volume-targeted methods offered superior image quality and vessel sharpness in most cases, suggesting that the choice of method depends on specific clinical goals.

Article Abstract

Purpose: To compare volume-targeted acquisition with whole-heart acquisition in 1.5-T free-breathing 3D coronary magnetic resonance angiography (MRA) with parallel imaging.

Materials And Methods: The major coronary arteries were imaged in 36 subjects using the whole-heart and volume-targeted acquisitions with comparable imaging parameters. The quantitative and semiquantitative data derived from these two acquisition methods were analyzed statistically, with P < 0.05 considered significant.

Results: Both the right coronary artery (RCA) / left circumflex artery (LCX)- and the left main (LM) / left anterior descending (LAD)-targeted acquisitions had similar results in navigator efficiencies and apparent signal-to-noise ratio (SNR) in comparison with whole-heart acquisition. Apparent contrast-to-noise ratio (CNR) of the volume-targeted imaging was significantly higher than that of the whole-heart imaging. The imaging time required for a whole-heart scan was significantly longer than each of the RCA/LCX- and LM/LAD-targeted acquisitions. However, the sum of scanning times derived from volume-targeted imaging was significantly longer than that of whole-heart acquisition. Both RCA/LCX- and LM/LAD-targeted acquisition yield higher vessel sharpness and overall image quality in comparison with whole-heart acquisition. The lengths of the major coronary arteries were not significantly different for the whole-heart and volume-targeted approaches. The whole-heart method was obviously superior to the volume-targeted method in terms of visualization of the posterior descending artery.

Conclusion: For current 1.5-T navigator coronary MRA, volume-targeted and whole-heart acquisitions have their own advantages and the choice of methods may vary in accordance with the different aims of clinical practice.

Download full-text PDF

Source
http://dx.doi.org/10.1002/jmri.24015DOI Listing

Publication Analysis

Top Keywords

whole-heart acquisition
20
whole-heart
11
volume-targeted
8
acquisition
8
major coronary
8
coronary arteries
8
whole-heart volume-targeted
8
comparison whole-heart
8
volume-targeted imaging
8
rca/lcx- lm/lad-targeted
8

Similar Publications

Background: Accurate measurements of flow and ventricular volume and function are critical for clinical decision-making in cardiovascular medicine. Cardiac magnetic resonance (CMR) is the current gold standard for ventricular functional evaluation but is relatively expensive and time-consuming, thus limiting the scale of clinical applications. New volumetric acquisition techniques, such as four-dimensional flow (4D-flow) and three-dimensional volumetric cine (3D-cine) MRI, could potentially reduce acquisition time without loss in accuracy; however, this has not been formally tested on a large scale.

View Article and Find Full Text PDF

Background: Three-dimensional (3D) whole-heart magnetic resonance imaging (MRI) is an excellent tool to check the heart anatomy of patients with congenital and acquired heart disease. However, most 3D whole-heart MRI acquisitions take a long time to perform, and the sequence used is susceptible to banding artifacts.

Purpose: To validate an unsupervised neural network that can reduce acquisition time and improve image quality for 3D whole-heart MRI by superresolving low-resolution images.

View Article and Find Full Text PDF

Feasibility and Clinical Application of 5-T Noncontrast Dixon Whole-Heart Coronary MR Angiography: A Prospective Study.

Radiology

October 2024

From the Department of Radiology, Zhongshan Hospital, Fudan University, No. 180 Fenglin Rd, Shanghai 200032, China (H.L., X.M., X.Z., X.Q., Y.C., H.J., M.Z.); Shanghai Institute of Medical Imaging, Shanghai, China (H.L., X.M., X.Z., X.Q., Y.C., H.J., M.Z.); United Imaging Healthcare, Shanghai, China (D.W., S.Z., R.W., G.L.); National Engineering Research Center of Advanced Magnetic Resonance Technologies for Diagnosis and Therapy, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China (C.H.); and Department of Radiology, Zhongshan Hospital (Minhang Meilong Branch), Fudan University and Shanghai Geriatric Medical Center, Shanghai, China (H.J., M.Z.).

Article Synopsis
  • Coronary MR angiography (CMRA) at 5 T potentially outperforms 3 T due to better image quality and sensitivity in detecting coronary artery disease (CAD).
  • The study included 79 patients and 8 volunteers, comparing 5-T and 3-T imaging techniques, with 5 T showing higher per-segment sensitivity for coronary artery calcium and better consistency with coronary CT angiography (CCTA).
  • Overall, 5-T noncontrast CMRA could be a promising clinical tool for diagnosing CAD, though the specific diagnostic performance metrics varied between 5 T and 3 T.
View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to create and assess a new method for conducting free-breathing 3D whole-heart Cardiac Magnetic Resonance Angiography (CMRA) without contrast agents at a lower magnetic field strength of 0.55T.
  • To achieve this, researchers optimized pulse sequences and imaging techniques, incorporating advanced methods like low-rank denoising and respiratory motion correction, and tested their approach on 11 healthy volunteers.
  • Results showed that the new method produced high-quality images with minimal artifacts in just 6 minutes, matching the performance of higher field strength systems, paving the way for future testing in patients with heart conditions.
View Article and Find Full Text PDF
Article Synopsis
  • The study investigated the effects of tafamidis treatment on cardiac amyloidosis using Tc-99m-PYP SPECT/CT imaging, focusing on changes in tracer uptake over time.
  • A total of 22 patients were followed for an average of 16.8 months, with significant reductions in standardized uptake values (SUVs) and other metrics indicating decreased amyloid burden in the heart.
  • The findings suggest that tafamidis therapy reduces cardiac amyloidosis, but further research is necessary to refine the quantification process and establish optimal measurement techniques.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!